Amid bitter battles over the state budget, radiologists in the Nutmeg State continue to struggle for the wherewithal to serve Medicaid patients—not least low-income women in need of diagnostic and screening mammography.

LOS ANGELES--(BUSINESS WIRE)--White Memorial Medical Center, a member of the Adventist Health System and a 353-bed hospital in downtown Los Angeles, celebrated the installation of a new mammography system donated by FUJIFILM Medical Systems U.S.A., Inc. and National Breast Cancer Foundation (NBCF) on March 23, 2016. A ceremony unveiled Fujifilm’s Aspire Cristalle at White Memorial Medical Center that will help meet the screening needs of women and assist medical professionals in the early detection and diagnosis of breast cancer.     

The ability of Volpara Solutions’ volumetric breast density and analytics data to help maintain accuracy and consistent quality in breast screening is the focus of numerous abstracts accepted for presentation at the European Congress of Radiology (ECR) meeting, March 2-6, 2016. (Booth #623). Eight studies – six posters and two oral presentations – highlight the use of Volpara's automated breast density and quantitative breast imaging software tools to provide breast density results correlated to the 4th and 5th Editions of the BI-RADS Atlas, to monitor temporal changes in breast density, and improve mammographic compression and positioning.

The authors of a study published online in JAMA Oncology Feb. 11 are drawing from their “Angelina effect”-supporting data to urge physicians to follow National Comprehensive Cancer Network guidelines by recommending genetic testing and counseling for all breast-cancer patients 50 and younger. 

Breast MRI examinations assessed using BI-RADS guidelines don’t always coincide with expected clinical management recommendations, according to results of a study published online in the American Journal of Roentgenology.

Architectural distortion, the non-mass but potentially ominous clinical feature observed in many breast imaging procedures, is less likely to signal malignancy when it’s detected on screening mammography rather than diagnostic mammography or when it does not correlate with a subsequent targeted ultrasound exam.

A large British study has found a significant negative association between ductal carcinoma in situ (DCIS) cases detected at screening and invasive cancers forming in the three-year period afterward. 

Already the best-selling modality for breast imaging in the U.S., digital breast tomosynthesis is also the fastest growing.